Caris Life Sciences (CAI) shares rose 33% in their debut Wednesday on Nasdaq following the company's initial public offering of 23.5 million shares priced at $21 each.
The stock traded at $27.86 around midday after opening at $27 and rising as high as $29.40.
The company granted underwriters an option to buy up to an additional 3.53 million shares at the IPO price.
The IPO is expected to close Friday.
Price: 27.86, Change: +6.86, Percent Change: +32.52
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。